Pricing and Reimbursement Policies in Estonian Pharmaceutical Market
The case study provides an overview of the main features of the pharmaceuticals pricing andreimbursement policies in Estonia, based on a review of regulations and literature, and data analysis. The first chapter of the report provides background in...
Main Author: | |
---|---|
Format: | Report |
Language: | English |
Published: |
World Bank, Washington, DC
2020
|
Subjects: | |
Online Access: | http://documents.worldbank.org/curated/en/209011593100198695/Pricing-and-reimbursement-policies-in-Estonian-pharmaceutical-market http://hdl.handle.net/10986/34189 |
id |
okr-10986-34189 |
---|---|
recordtype |
oai_dc |
spelling |
okr-10986-341892021-05-25T09:55:04Z Pricing and Reimbursement Policies in Estonian Pharmaceutical Market Habicht, Triin PHARMACEUTICAL PRICING HEALTH INSURANCE HEALTH EXPENDITURE HEALTH SYSTEM HOSPITAL PROCUREMENT MEDICINE REIMBURSEMENT The case study provides an overview of the main features of the pharmaceuticals pricing andreimbursement policies in Estonia, based on a review of regulations and literature, and data analysis. The first chapter of the report provides background information on the Estonian health system context and overall description of the pharmaceutical sector. The second chapter focuses on the pricing policies used for the retail and hospital sector medicines, while outlining the impact of current policies. The third chapter takes a closer look into the reimbursement policies for outpatient and inpatient medicines. Finally, some conclusions from the case study are provided. 2020-07-24T14:53:10Z 2020-07-24T14:53:10Z 2018-04 Report http://documents.worldbank.org/curated/en/209011593100198695/Pricing-and-reimbursement-policies-in-Estonian-pharmaceutical-market http://hdl.handle.net/10986/34189 English CC BY 3.0 IGO http://creativecommons.org/licenses/by/3.0/igo World Bank World Bank, Washington, DC Economic & Sector Work Economic & Sector Work :: Other Health Study Europe and Central Asia Bulgaria |
repository_type |
Digital Repository |
institution_category |
Foreign Institution |
institution |
Digital Repositories |
building |
World Bank Open Knowledge Repository |
collection |
World Bank |
language |
English |
topic |
PHARMACEUTICAL PRICING HEALTH INSURANCE HEALTH EXPENDITURE HEALTH SYSTEM HOSPITAL PROCUREMENT MEDICINE REIMBURSEMENT |
spellingShingle |
PHARMACEUTICAL PRICING HEALTH INSURANCE HEALTH EXPENDITURE HEALTH SYSTEM HOSPITAL PROCUREMENT MEDICINE REIMBURSEMENT Habicht, Triin Pricing and Reimbursement Policies in Estonian Pharmaceutical Market |
geographic_facet |
Europe and Central Asia Bulgaria |
description |
The case study provides an overview of
the main features of the pharmaceuticals pricing
andreimbursement policies in Estonia, based on a review of
regulations and literature, and data analysis. The first
chapter of the report provides background information on the
Estonian health system context and overall description of
the pharmaceutical sector. The second chapter focuses on the
pricing policies used for the retail and hospital sector
medicines, while outlining the impact of current policies.
The third chapter takes a closer look into the reimbursement
policies for outpatient and inpatient medicines. Finally,
some conclusions from the case study are provided. |
format |
Report |
author |
Habicht, Triin |
author_facet |
Habicht, Triin |
author_sort |
Habicht, Triin |
title |
Pricing and Reimbursement Policies in Estonian Pharmaceutical Market |
title_short |
Pricing and Reimbursement Policies in Estonian Pharmaceutical Market |
title_full |
Pricing and Reimbursement Policies in Estonian Pharmaceutical Market |
title_fullStr |
Pricing and Reimbursement Policies in Estonian Pharmaceutical Market |
title_full_unstemmed |
Pricing and Reimbursement Policies in Estonian Pharmaceutical Market |
title_sort |
pricing and reimbursement policies in estonian pharmaceutical market |
publisher |
World Bank, Washington, DC |
publishDate |
2020 |
url |
http://documents.worldbank.org/curated/en/209011593100198695/Pricing-and-reimbursement-policies-in-Estonian-pharmaceutical-market http://hdl.handle.net/10986/34189 |
_version_ |
1764480282226851840 |